Compound_ID	Active	Smiles	canonical_smi	Set	Set_type	MW	HBD	HBA	NRB	NR	NAR	PSA	Standard Type	Standard Relation	Standard Units	Standard Value	Assay ChEMBL ID	Assay Description	BAO Label
CHEMBL3666266	1.0	CC(CO)(CO)n1cc(C(=O)c2cncc(NC(=O)c3ccc(C(F)(F)F)c(F)c3)c2)c2cncnc21	CC(CO)(CO)n1cc(C(=O)c2cncc(NC(=O)c3ccc(C(F)(F)F)c(F)c3)c2)c2cncnc21	G2 active	External	517.44	3	7	7	4	4	130.23	IC50	'='	nM	69.0	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL3981003	1.0	Cc1cc(C(F)(F)F)nn1CC(=O)Nc1cncc(C(=O)c2cn(C(C)C)c3c(F)cncc23)c1	Cc1cc(C(F)(F)F)nn1CC(=O)Nc1cncc(C(=O)c2cn(C(C)C)c3c(F)cncc23)c1	G2 active	External	488.45	1	5	6	4	4	94.7	IC50	'='	nM	11.4	CHEMBL3887111	HTRF Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat#62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors.Assay Details: Invitrogen Amino FAC FAC Assay ReactionTarget Cat# acids enzyme ATP TimeTRKA PV3144 aa 441-4 nM 40 uM 35 min (NTRK1) 796 TRKB PV3616 aa 526-1 nM 1.4 uM 40 min (NTRK2) 838 TRKC PV3617 aa 510- 10 nM 15 uM 30 min (NTRK3) 8250.5 mM stock solutions of test compounds are prepared and serially diluted in 100% DMSO. A standard curve using the compound of Example 135 disclosed in WO2005/116035 of 150 uM is also prepared on each test plate. High percentage effect (HPE) is defined by 150 uM.	single protein format
CHEMBL3675953	1.0	COCCOc1cc(F)cc([C@H]2CCCN2c2ccn3ncc(C(N)=O)c3n2)c1	COCCOc1cc(F)cc([C@H]2CCCN2c2ccn3ncc(C(N)=O)c3n2)c1	G2 active	External	399.43	1	6	7	4	3	94.98	IC50	'='	nM	34.85	CHEMBL3887070	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL3676013	1.0	COc1ncc(F)cc1[C@H]1CCCN1c1ccn2ncc(C(=O)N3CC(O)C3)c2n1	COc1ncc(F)cc1[C@H]1CCCN1c1ccn2ncc(C(=O)N3CC(O)C3)c2n1	G2 active	External	412.43	1	7	4	5	3	96.09	IC50	'='	nM	32.7	CHEMBL3887070	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL3676080	1.0	CC(C)NC(=O)c1cnn2ccc(N3[C@H](CO)CC[C@@H]3c3cncc(F)c3)nc12	CC(C)NC(=O)c1cnn2ccc(N3[C@H](CO)CC[C@@H]3c3cncc(F)c3)nc12	G2 active	External	398.44	2	6	5	4	3	95.65	IC50	'='	nM	15.3	CHEMBL3887070	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL3671408	1.0	C[C@@H](CO)n1cc(C(=O)c2cncc(NC(=O)Cn3cc4ccccc4n3)c2)c2cncnc21	C[C@@H](CO)n1cc(C(=O)c2cncc(NC(=O)Cn3cc4ccccc4n3)c2)c2cncnc21	G2 active	External	455.48	2	7	7	5	5	127.82	IC50	'='	nM	11.1	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL211883	1.0	CNC(=O)Nc1snc(SC2CCc3cc(Cl)ccc32)c1C(N)=O	CNC(=O)Nc1snc(SC2CCc3cc(Cl)ccc32)c1C(N)=O	G2 active	External	382.9	3	4	4	3	2	97.11	IC50	'='	nM	8.0	CHEMBL867240	Inhibition of TrkA kinase	single protein format
CHEMBL211880	1.0	CC[C@H](Sc1nsc(NC(=O)NC)c1C(N)=O)c1ccc(Cl)cc1	CC[C@H](Sc1nsc(NC(=O)NC)c1C(N)=O)c1ccc(Cl)cc1	G2 active	External	384.91	3	4	6	2	2	97.11	IC50	'='	nM	52.0	CHEMBL867240	Inhibition of TrkA kinase	single protein format
CHEMBL3675929	1.0	O=C(NC1CC1)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12	O=C(NC1CC1)c1cnn2ccc(N3CCC[C@@H]3c3cncc(F)c3)nc12	G2 active	External	366.4	1	5	4	5	3	75.42	IC50	'='	nM	7.4	CHEMBL3887070	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL3675943	1.0	CC1(C)CC[C@H](c2cc(F)ccc2F)N1c1ccn2ncc(C(N)=O)c2n1	CC1(C)CC[C@H](c2cc(F)ccc2F)N1c1ccn2ncc(C(N)=O)c2n1	G2 active	External	371.39	1	4	3	4	3	76.52	IC50	'='	nM	5.1	CHEMBL3887070	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL254690	1.0	CCC(=O)N1CCN(C(=O)c2cc(Sc3cnc(Nc4cccc(Br)n4)s3)ccc2C)CC1	CCC(=O)N1CCN(C(=O)c2cc(Sc3cnc(Nc4cccc(Br)n4)s3)ccc2C)CC1	G2 active	External	546.52	1	6	6	4	3	78.43	IC50	'='	nM	21.0	CHEMBL928869	Inhibition of TrkA	single protein format
CHEMBL2158227	1.0	CS(=O)(=O)CCN1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1	CS(=O)(=O)CCN1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1	G2 active	External	481.62	2	6	7	4	2	118.95	IC50	'='	nM	30.0	CHEMBL2161435	Inhibition of TRKA	single protein format
CHEMBL3673442	1.0	COc1ccc(COc2ccc(Cn3cnc4cc(-c5cnn(C6CCNCC6)c5)ccc43)cc2OC)cn1	COc1ccc(COc2ccc(Cn3cnc4cc(-c5cnn(C6CCNCC6)c5)ccc43)cc2OC)cn1	G2 active	External	524.63	1	7	9	6	5	88.25	IC50	'='	nM	6.0	CHEMBL3887112	Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkA (0.4 nM, Carna 08-186) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 uM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 200 pM TrkA, 1.5 uM peptide substrate and 55 uM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij.	single protein format
CHEMBL3676096	1.0	Cn1cc(F)cc([C@H]2CCCN2c2ccn3ncc(C(=O)N[C@@H]4CCCC[C@H]4O)c3n2)c1=O	Cn1cc(F)cc([C@H]2CCCN2c2ccn3ncc(C(=O)N[C@@H]4CCCC[C@H]4O)c3n2)c1=O	G2 active	External	454.51	2	6	4	5	3	104.76	IC50	'='	nM	10.7	CHEMBL3887070	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL3666293	1.0	Cn1cc(C(=O)c2cncc(NC(=O)Nc3ccc(C(F)(F)F)cc3)c2)c2cncnc21	Cn1cc(C(=O)c2cncc(NC(=O)Nc3ccc(C(F)(F)F)cc3)c2)c2cncnc21	G2 active	External	440.39	2	5	4	4	4	101.8	IC50	'='	nM	61.4	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL3671421	1.0	COCC(C)(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cn3)c2)c2cnc(N)nc21	COCC(C)(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cn3)c2)c2cnc(N)nc21	G2 active	External	493.96	2	8	8	4	4	137.91	IC50	'='	nM	3.88	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL403342	1.0	Cc1ccc(Sc2cnc(Nc3ccccn3)s2)cc1C(=O)NCCC#N	Cc1ccc(Sc2cnc(Nc3ccccn3)s2)cc1C(=O)NCCC#N	G2 active	External	395.51	2	6	7	3	3	90.7	IC50	'='	nM	65.0	CHEMBL928869	Inhibition of TrkA	single protein format
CHEMBL3962940	1.0	O=C(Nc1cc(C(=O)c2cn(C3COC3)c3ccncc23)ccn1)c1cccc(OC(F)(F)F)c1	O=C(Nc1cc(C(=O)c2cn(C3COC3)c3ccncc23)ccn1)c1cccc(OC(F)(F)F)c1	G2 active	External	482.42	1	6	6	5	4	95.34	IC50	'='	nM	33.0	CHEMBL3887111	HTRF Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat#62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors.Assay Details: Invitrogen Amino FAC FAC Assay ReactionTarget Cat# acids enzyme ATP TimeTRKA PV3144 aa 441-4 nM 40 uM 35 min (NTRK1) 796 TRKB PV3616 aa 526-1 nM 1.4 uM 40 min (NTRK2) 838 TRKC PV3617 aa 510- 10 nM 15 uM 30 min (NTRK3) 8250.5 mM stock solutions of test compounds are prepared and serially diluted in 100% DMSO. A standard curve using the compound of Example 135 disclosed in WO2005/116035 of 150 uM is also prepared on each test plate. High percentage effect (HPE) is defined by 150 uM.	single protein format
CHEMBL3666256	1.0	CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C(F)(F)F)n3)c2)c2cnc(N)nc21	CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C(F)(F)F)n3)c2)c2cnc(N)nc21	G2 active	External	472.43	2	7	6	4	4	133.61	IC50	'='	nM	5.18	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL3678293	1.0	COc1ccc(COc2ccc(C(C)n3c(N)nc4cc(-c5ccc(F)cc5)ccc43)cc2OC)cn1	COc1ccc(COc2ccc(C(C)n3c(N)nc4cc(-c5ccc(F)cc5)ccc43)cc2OC)cn1	G2 active	External	498.56	1	6	8	5	5	84.42	IC50	'='	nM	85.0	CHEMBL3887112	Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkA (0.4 nM, Carna 08-186) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 uM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 200 pM TrkA, 1.5 uM peptide substrate and 55 uM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij.	single protein format
CHEMBL4853913	1.0	CN1CCN(c2ccc(NC(=O)[C@@H]3CCCN3c3nc(Nc4cc(F)cc(F)c4)ncc3Cl)cc2C(=O)N(C)C)CC1	CN1CCN(c2ccc(NC(=O)[C@@H]3CCCN3c3nc(Nc4cc(F)cc(F)c4)ncc3Cl)cc2C(=O)N(C)C)CC1	G2 active	External	599.09	2	8	7	5	3	96.94	IC50	'='	nM	6.4	CHEMBL4811213	Inhibition of human TRKA assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	single protein format
CHEMBL4113000	1.0	Cc1cnc(C(=O)Nc2cnn3ccc(N4CCC[C@@H]4c4cccc(F)c4)nc23)cn1	Cc1cnc(C(=O)Nc2cnn3ccc(N4CCC[C@@H]4c4cccc(F)c4)nc23)cn1	G2 active	External	417.45	1	6	4	5	4	88.31	IC50	'='	nM	6.6	CHEMBL3887076	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking. The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL2152269	1.0	Nc1cncc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1	Nc1cncc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1	G2 active	External	287.33	2	4	2	4	4	80.48	IC50	'='	nM	69.6	CHEMBL2157053	Inhibition of TRKA assessed as [gamma33P]ATP incorporation into substrate	single protein format
CHEMBL3671418	1.0	CN(C(=O)Cc1ccc(Cl)cc1)c1cncc(C(=O)c2cn(C(C)(C)C)c3ncncc23)c1	CN(C(=O)Cc1ccc(Cl)cc1)c1cncc(C(=O)c2cn(C(C)(C)C)c3ncncc23)c1	G2 active	External	461.95	0	5	5	4	4	80.98	IC50	'='	nM	31.6	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL3671468	1.0	CS(=O)(=O)c1cccc(CC(=O)Nc2cncc(C(=O)c3cn(C45CC(C4)C5)c4nc(N)ncc34)c2)c1	CS(=O)(=O)c1cccc(CC(=O)Nc2cncc(C(=O)c3cn(C45CC(C4)C5)c4nc(N)ncc34)c2)c1	G2 active	External	516.58	2	8	7	7	4	149.93	IC50	'='	nM	8.11	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL3661616	1.0	CC(C)(CO)n1cc(C(=O)c2cncc(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)c2cncnc21	CC(C)(CO)n1cc(C(=O)c2cncc(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)c2cncnc21	G2 active	External	497.48	2	6	7	4	4	110.0	IC50	'='	nM	3.61	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL3661464	1.0	CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cc3)c2)c2cncnc21	CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cc3)c2)c2cncnc21	G2 active	External	433.9	1	5	6	4	4	89.77	IC50	'='	nM	10.9	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL3964567	1.0	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cnc(Oc3ccc(-c4cnc(N5CCCC5=O)s4)cc3)nc2)cc1C	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cnc(Oc3ccc(-c4cnc(N5CCCC5=O)s4)cc3)nc2)cc1C	G2 active	External	622.76	2	7	7	6	5	127.16	IC50	'='	nM	80.0	CHEMBL3887906	LanthaScreen Kinase Assay: TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, LanthaScreen Tb-PY20 and TR-FRET Dilution Buffer), TrkA (Invitrogen), ATP (Sigma-Aldrich), a kinase reaction buffer (50 mM HEPES buffer (Sigma-Aldrich) (pH 7.5) containing 0.01% Brij35 (Sigma-Aldrich), 10 mM MgCl2 (Sigma-Aldrich) and 1 mM EGTA (Sigma-Aldrich)) and 0.5 M EDTA (pH 8.0) (Invitrogen).The present compound was dissolved in dimethylsulfoxide (hereinafter abbreviated as DMSO) to prepare a 10 mM solution. The test compound at 10 mM was distributed into a 96-well plate and serially diluted with DMSO with the geometrical ratio of 3. The serial dilutions (DMSO solutions) were diluted with the kinase reaction buffer to 20-fold to prepare solutions of the present compound with 5-times concentrations (DMSO concentration: 5%). TrkA was diluted with the kinase reaction buffer to prepare a solution at 38.5 ng/mL (enzyme solution). Adenosine	single protein format
CHEMBL3666272	1.0	O=C(Nc1cncc(C(=O)c2cn(C(CO)CO)c3ncncc23)c1)c1cccc(OC(F)(F)F)c1	O=C(Nc1cncc(C(=O)c2cn(C(CO)CO)c3ncncc23)c1)c1cccc(OC(F)(F)F)c1	G2 active	External	501.42	3	8	8	4	4	139.46	IC50	'='	nM	39.0	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL3671456	1.0	CC(C)n1cc(C(=O)c2c[nH]c(=O)c(NC(=O)Cc3ccc(Cl)cn3)c2)c2cncnc21	CC(C)n1cc(C(=O)c2c[nH]c(=O)c(NC(=O)Cc3ccc(Cl)cn3)c2)c2cncnc21	G2 active	External	450.89	2	6	6	4	4	122.63	IC50	'='	nM	71.2	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL2037226	1.0	Cc1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1	Cc1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1	G2 active	External	535.5	5	3	5	5	4	98.05	IC50	'='	nM	8.0	CHEMBL2038860	Inhibition of TRKA by HTRF assay	single protein format
CHEMBL3678288	1.0	COc1ccc(COc2ccc(Cn3c(N)nc4cc(C#CC5CCCCC5)cnc43)cc2OC)cn1	COc1ccc(COc2ccc(Cn3c(N)nc4cc(C#CC5CCCCC5)cnc43)cc2OC)cn1	G2 active	External	497.6	1	7	7	5	4	97.31	IC50	'='	nM	65.0	CHEMBL3887112	Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkA (0.4 nM, Carna 08-186) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 uM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 200 pM TrkA, 1.5 uM peptide substrate and 55 uM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij.	single protein format
CHEMBL3671310	1.0	C[C@@H](Cc1c(F)c(F)cc(F)c1F)Nc1cc[nH]c(=O)c1-c1nc2cc3c(cc2[nH]1)C(=O)N(CCN(C)C)C3=O	C[C@@H](Cc1c(F)c(F)cc(F)c1F)Nc1cc[nH]c(=O)c1-c1nc2cc3c(cc2[nH]1)C(=O)N(CCN(C)C)C3=O	G2 active	External	556.52	3	6	8	5	4	114.19	IC50	'='	nM	12.24	CHEMBL3887072	In Vitro Kinase Activity Assay: Compounds to be tested were dissolved in 100% DMSO in a range of concentrations from 10-8 to 10-3 M including negative control (DMSO), then diluted with Kinase Buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, and 2 mM DTT, added fresh) to 4x the final concentration. The final curve included 11 concentrations (10-11 to 10-5 M) plus negative control DMSO tested in triplicate.Kinase and ATP concentrations necessary for optimal activity were determined in separate experiments. (Table 2). Briefly, increasing concentrations of kinase were incubated in a fixed concentration of ATP (200 uM) in Kinase Buffer to determine maximal activity at various time points (30-120 min). The concentration of kinase that resulted in maximal activity with the shortest incubation time was then incubated in Kinase Buffer with increasing concentrations of ATP.	single protein format
CHEMBL370493	1.0	CC1(C)O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@]1(O)CO	CC1(C)O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@]1(O)CO	G2 active	External	455.51	4	4	2	7	5	99.51	IC50	'='	nM	4.0	CHEMBL832085	Inhibition of baculovirus expressed human trkA	single protein format
CHEMBL3922568	1.0	Cc1cc(C)n(CC(=O)Nc2cc(C(=O)c3cn(C(C)C)c4ccncc34)ccn2)n1	Cc1cc(C)n(CC(=O)Nc2cc(C(=O)c3cn(C(C)C)c4ccncc34)ccn2)n1	G2 active	External	416.49	1	5	6	4	4	94.7	IC50	'='	nM	33.0	CHEMBL3887111	HTRF Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat#62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors.Assay Details: Invitrogen Amino FAC FAC Assay ReactionTarget Cat# acids enzyme ATP TimeTRKA PV3144 aa 441-4 nM 40 uM 35 min (NTRK1) 796 TRKB PV3616 aa 526-1 nM 1.4 uM 40 min (NTRK2) 838 TRKC PV3617 aa 510- 10 nM 15 uM 30 min (NTRK3) 8250.5 mM stock solutions of test compounds are prepared and serially diluted in 100% DMSO. A standard curve using the compound of Example 135 disclosed in WO2005/116035 of 150 uM is also prepared on each test plate. High percentage effect (HPE) is defined by 150 uM.	single protein format
CHEMBL258434	1.0	C[C@H](OC(=O)NCc1ccccc1)[C@H]1c2ccccc2-c2c3c(c4c([nH]c5ccccc54)c21)CNC3=O	C[C@H](OC(=O)NCc1ccccc1)[C@H]1c2ccccc2-c2c3c(c4c([nH]c5ccccc54)c21)CNC3=O	G2 active	External	487.56	3	3	4	7	5	83.22	IC50	'='	nM	52.0	CHEMBL934847	Inhibition of human recombinant TrkA	single protein format
CHEMBL4108101	1.0	O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3Cl)nc12)N1CC(O)C1	O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3Cl)nc12)N1CC(O)C1	G2 active	External	430.87	2	5	3	5	3	86.0	IC50	'='	nM	13.7	CHEMBL3887076	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking. The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL3676040	1.0	CN1CCN(CCNC(=O)c2cnn3ccc(N4CCCC4c4cc(F)ccc4F)nc23)CC1	CN1CCN(CCNC(=O)c2cnn3ccc(N4CCCC4c4cc(F)ccc4F)nc23)CC1	G2 active	External	469.54	1	6	6	5	3	69.01	IC50	'='	nM	4.7	CHEMBL3887070	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL104333	1.0	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C	G2 active	External	383.43	2	4	3	4	3	103.42	IC50	'='	nM	3.78	CHEMBL4765713	Inhibition of TrkA (unknown origin)	single protein format
CHEMBL3675955	1.0	CC(C)(C)NC(=O)c1cnn2ccc(N3CCCC3c3cc(F)cnc3CO)nc12	CC(C)(C)NC(=O)c1cnn2ccc(N3CCCC3c3cc(F)cnc3CO)nc12	G2 active	External	412.47	2	6	4	4	3	95.65	IC50	'='	nM	1.8	CHEMBL3887070	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL2152288	1.0	Nc1cc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1	Nc1cc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1	G2 active	External	509.51	3	5	5	5	5	113.76	IC50	'='	nM	1.67	CHEMBL2157053	Inhibition of TRKA assessed as [gamma33P]ATP incorporation into substrate	single protein format
CHEMBL3673437	1.0	COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cncnc5)ccc43)cc2OC)cc1	COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cncnc5)ccc43)cc2OC)cc1	G2 active	External	467.53	1	7	8	5	5	97.31	IC50	'='	nM	86.0	CHEMBL3887112	Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkA (0.4 nM, Carna 08-186) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 uM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 200 pM TrkA, 1.5 uM peptide substrate and 55 uM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij.	single protein format
CHEMBL4780049	1.0	Fc1cc(Cl)cc(CNc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1	Fc1cc(Cl)cc(CNc2ccc3[nH]nc(/C=C/c4ccccn4)c3c2)c1	G2 active	External	378.84	2	3	5	4	4	53.6	IC50	'='	nM	2.0	CHEMBL4772612	Inhibition of TrkA (unknown origin) using Tyr1 peptide as substrate in presence of ATP measured after 2 hrs by FRET-based Z-Lyte kinase assay	single protein format
CHEMBL3673466	1.0	COc1ccc(COc2ccc(Cn3cnc4cc(-c5nnc(C6CCNCC6)o5)cnc43)cc2OC)cn1	COc1ccc(COc2ccc(Cn3cnc4cc(-c5nnc(C6CCNCC6)o5)cnc43)cc2OC)cn1	G2 active	External	527.59	1	10	9	6	5	122.24	IC50	'='	nM	51.0	CHEMBL3887112	Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkA (0.4 nM, Carna 08-186) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 uM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 200 pM TrkA, 1.5 uM peptide substrate and 55 uM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij.	single protein format
CHEMBL3900668	1.0	CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3cc(C4CC4)nn3)c2)c2cnccc21	CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3cc(C4CC4)nn3)c2)c2cnccc21	G2 active	External	429.48	1	6	7	5	4	107.59	IC50	'='	nM	68.2	CHEMBL3887111	HTRF Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat#62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors.Assay Details: Invitrogen Amino FAC FAC Assay ReactionTarget Cat# acids enzyme ATP TimeTRKA PV3144 aa 441-4 nM 40 uM 35 min (NTRK1) 796 TRKB PV3616 aa 526-1 nM 1.4 uM 40 min (NTRK2) 838 TRKC PV3617 aa 510- 10 nM 15 uM 30 min (NTRK3) 8250.5 mM stock solutions of test compounds are prepared and serially diluted in 100% DMSO. A standard curve using the compound of Example 135 disclosed in WO2005/116035 of 150 uM is also prepared on each test plate. High percentage effect (HPE) is defined by 150 uM.	single protein format
CHEMBL3675941	1.0	CONC(=O)c1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12	CONC(=O)c1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12	G2 active	External	373.36	1	5	4	4	3	71.76	IC50	'='	nM	0.6	CHEMBL3887070	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL2037210	1.0	Cc1cc(C(=O)Nc2cccc(Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)c2)cc(N2CCN(C)CC2)c1	Cc1cc(C(=O)Nc2cccc(Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)c2)cc(N2CCN(C)CC2)c1	G2 active	External	532.65	4	5	6	6	4	92.5	IC50	'='	nM	16.0	CHEMBL2038860	Inhibition of TRKA by HTRF assay	single protein format
CHEMBL3675920	1.0	CC(C)(C)NC(=O)c1cnn2ccc(N3C[C@H](O)C[C@@H]3c3cccc(F)c3)nc12	CC(C)(C)NC(=O)c1cnn2ccc(N3C[C@H](O)C[C@@H]3c3cccc(F)c3)nc12	G2 active	External	397.45	2	5	3	4	3	82.76	IC50	'='	nM	48.3	CHEMBL3887070	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL3936350	1.0	CC(C)(CO)n1cc(C(=O)c2cc(NC(=O)Cn3cc(C(F)(F)F)nn3)ccn2)c2cnccc21	CC(C)(CO)n1cc(C(=O)c2cc(NC(=O)Cn3cc(C(F)(F)F)nn3)ccn2)c2cnccc21	G2 active	External	487.44	2	7	7	4	4	127.82	IC50	'='	nM	79.3	CHEMBL3887111	HTRF Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat#62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors.Assay Details: Invitrogen Amino FAC FAC Assay ReactionTarget Cat# acids enzyme ATP TimeTRKA PV3144 aa 441-4 nM 40 uM 35 min (NTRK1) 796 TRKB PV3616 aa 526-1 nM 1.4 uM 40 min (NTRK2) 838 TRKC PV3617 aa 510- 10 nM 15 uM 30 min (NTRK3) 8250.5 mM stock solutions of test compounds are prepared and serially diluted in 100% DMSO. A standard curve using the compound of Example 135 disclosed in WO2005/116035 of 150 uM is also prepared on each test plate. High percentage effect (HPE) is defined by 150 uM.	single protein format
CHEMBL4777109	1.0	C[C@H](c1cc(F)ccc1F)N(C)c1ccn2ncc(NC(=S)N3CC[C@H](O)C3)c2n1	C[C@H](c1cc(F)ccc1F)N(C)c1ccn2ncc(NC(=S)N3CC[C@H](O)C3)c2n1	G2 active	External	432.5	2	7	4	4	3	68.93	IC50	'='	nM	19.0	CHEMBL4678168	Inhibition of Trk-A (unknown origin)	single protein format
CHEMBL3671445	1.0	CC1(n2cc(C(=O)c3cncc(NC(=O)Cc4ccc(C(F)(F)F)c(F)c4)c3)c3cncnc32)COC1	CC1(n2cc(C(=O)c3cncc(NC(=O)Cc4ccc(C(F)(F)F)c(F)c4)c3)c3cncnc32)COC1	G2 active	External	513.45	1	6	6	5	4	99.0	IC50	'='	nM	17.9	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL4784645	1.0	C[C@@H](Nc1ccn2ncc(NC(=O)N3CC[C@H](O)C3)c2n1)c1cc(F)ccc1F	C[C@@H](Nc1ccn2ncc(NC(=O)N3CC[C@H](O)C3)c2n1)c1cc(F)ccc1F	G2 active	External	402.41	3	5	4	4	3	94.79	IC50	'='	nM	1.9	CHEMBL4678168	Inhibition of Trk-A (unknown origin)	single protein format
CHEMBL3898527	1.0	CC(C)(CO)n1cc(C(=O)c2cncc(NC(=O)Cn3cc(C(F)(F)F)nn3)c2)c2cncc(F)c21	CC(C)(CO)n1cc(C(=O)c2cncc(NC(=O)Cn3cc(C(F)(F)F)nn3)c2)c2cncc(F)c21	G2 active	External	505.43	2	7	7	4	4	127.82	IC50	'='	nM	20.0	CHEMBL3887111	HTRF Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat#62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors.Assay Details: Invitrogen Amino FAC FAC Assay ReactionTarget Cat# acids enzyme ATP TimeTRKA PV3144 aa 441-4 nM 40 uM 35 min (NTRK1) 796 TRKB PV3616 aa 526-1 nM 1.4 uM 40 min (NTRK2) 838 TRKC PV3617 aa 510- 10 nM 15 uM 30 min (NTRK3) 8250.5 mM stock solutions of test compounds are prepared and serially diluted in 100% DMSO. A standard curve using the compound of Example 135 disclosed in WO2005/116035 of 150 uM is also prepared on each test plate. High percentage effect (HPE) is defined by 150 uM.	single protein format
CHEMBL3671312	1.0	CC(Cc1cc(F)ccc1F)Nc1cc[nH]c(=O)c1-c1nc2cc3c(cc2[nH]1)C(=O)N(C1CCN(C)CC1)C3=O	CC(Cc1cc(F)ccc1F)Nc1cc[nH]c(=O)c1-c1nc2cc3c(cc2[nH]1)C(=O)N(C1CCN(C)CC1)C3=O	G2 active	External	546.58	3	6	6	6	4	114.19	IC50	'='	nM	6.353	CHEMBL3887072	In Vitro Kinase Activity Assay: Compounds to be tested were dissolved in 100% DMSO in a range of concentrations from 10-8 to 10-3 M including negative control (DMSO), then diluted with Kinase Buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 10 mM MgCl2, 0.01% Tween-20, and 2 mM DTT, added fresh) to 4x the final concentration. The final curve included 11 concentrations (10-11 to 10-5 M) plus negative control DMSO tested in triplicate.Kinase and ATP concentrations necessary for optimal activity were determined in separate experiments. (Table 2). Briefly, increasing concentrations of kinase were incubated in a fixed concentration of ATP (200 uM) in Kinase Buffer to determine maximal activity at various time points (30-120 min). The concentration of kinase that resulted in maximal activity with the shortest incubation time was then incubated in Kinase Buffer with increasing concentrations of ATP.	single protein format
CHEMBL209506	1.0	NC(=O)c1c(SCc2ccc(Cl)cc2)nsc1Nc1ccc(O)nc1	NC(=O)c1c(SCc2ccc(Cl)cc2)nsc1Nc1ccc(O)nc1	G2 active	External	392.89	3	6	6	3	3	101.13	IC50	'='	nM	84.0	CHEMBL867240	Inhibition of TrkA kinase	single protein format
CHEMBL3897319	1.0	Cc1cc(C(F)(F)F)nn1CC(=O)Nc1ccnc(C(=O)c2cn(C(C)C)c3ccncc23)c1	Cc1cc(C(F)(F)F)nn1CC(=O)Nc1ccnc(C(=O)c2cn(C(C)C)c3ccncc23)c1	G2 active	External	470.46	1	5	6	4	4	94.7	IC50	'='	nM	10.6	CHEMBL3887111	HTRF Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat#62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors.Assay Details: Invitrogen Amino FAC FAC Assay ReactionTarget Cat# acids enzyme ATP TimeTRKA PV3144 aa 441-4 nM 40 uM 35 min (NTRK1) 796 TRKB PV3616 aa 526-1 nM 1.4 uM 40 min (NTRK2) 838 TRKC PV3617 aa 510- 10 nM 15 uM 30 min (NTRK3) 8250.5 mM stock solutions of test compounds are prepared and serially diluted in 100% DMSO. A standard curve using the compound of Example 135 disclosed in WO2005/116035 of 150 uM is also prepared on each test plate. High percentage effect (HPE) is defined by 150 uM.	single protein format
CHEMBL3906413	1.0	O=C(Cc1ccc(C(F)(F)F)cc1)Nc1cc(C(=O)c2cn(CCO)c3ccncc23)ccn1	O=C(Cc1ccc(C(F)(F)F)cc1)Nc1cc(C(=O)c2cn(CCO)c3ccncc23)ccn1	G2 active	External	468.44	2	5	7	4	4	97.11	IC50	'='	nM	20.2	CHEMBL3887111	HTRF Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat#62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors.Assay Details: Invitrogen Amino FAC FAC Assay ReactionTarget Cat# acids enzyme ATP TimeTRKA PV3144 aa 441-4 nM 40 uM 35 min (NTRK1) 796 TRKB PV3616 aa 526-1 nM 1.4 uM 40 min (NTRK2) 838 TRKC PV3617 aa 510- 10 nM 15 uM 30 min (NTRK3) 8250.5 mM stock solutions of test compounds are prepared and serially diluted in 100% DMSO. A standard curve using the compound of Example 135 disclosed in WO2005/116035 of 150 uM is also prepared on each test plate. High percentage effect (HPE) is defined by 150 uM.	single protein format
CHEMBL4111937	1.0	O=C(Nc1cnc2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nn12)N1CCOCC1	O=C(Nc1cnc2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nn12)N1CCOCC1	G2 active	External	428.44	1	5	3	5	3	75.0	IC50	'='	nM	23.7	CHEMBL3887826	ELISA Assay: An enzyme-linked immunosorbant assay (ELISA) was used to assess TrkA kinase activity in the presence of inhibitors. Immulon 4HBX 384-well microtiter plates (Thermo part #8755) were coated with a 0.025 mg/mL solution of poly (Glu, Ala, Tyr; 6:3:1; Sigma P3899). Various concentrations of test compound, 2.5 nM TrkA (Invitrogen Corp., histidine-tagged recombinant human TrkA, cytoplasmic domain), and 500 uM ATP were incubated for 25 minutes at ambient temperature in the coated plates while shaking. The assay buffer consisted of 25 mM MOPS pH 7.5, 0.005% (v/v) Triton X-100 and 5 mM MgCl2. The reaction mixture was removed from the plate by washing with PBS containing 0.1% (v/v) Tween 20. The phosphorylated reaction product was detected using 0.2 ug/mL of a phosphotyrosine specific monoclonal antibody (clone PY20) conjugated to horseradish peroxidase in conjunction with the TMB Peroxidase Substrate System (KPL).	single protein format
CHEMBL3673478	1.0	COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(C(F)(F)F)cc1	COc1cc(Cn2c(N)nc3cc(-c4cnn(C)c4)cnc32)ccc1OCc1ccc(C(F)(F)F)cc1	G2 active	External	508.5	1	6	7	5	5	93.01	IC50	'='	nM	0.2	CHEMBL3887112	Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkA (0.4 nM, Carna 08-186) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 uM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 200 pM TrkA, 1.5 uM peptide substrate and 55 uM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij.	single protein format
CHEMBL5094232	1.0	CC1(C)Oc2c(ncnc2Nc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccccc3)cc2)NC1=O	CC1(C)Oc2c(ncnc2Nc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccccc3)cc2)NC1=O	G2 active	External	526.6	4	7	5	5	4	135.09	IC50	'='	nM	35.0	CHEMBL5045112	Inhibition of wild type TrkA (unknown origin) using poly(Glu: Tyr) as substrate preincubated for 15 mins followed by substrate addition and further incubated for 30 mins in presence of [gamma-33P]ATP by scintillation counting method	single protein format
CHEMBL3596879	1.0	Cn1cc(-c2cncc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)n2)cn1	Cn1cc(-c2cncc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)on4)c3)n2)cn1	G2 active	External	433.47	2	7	5	4	4	119.99	IC50	'='	nM	24.0	CHEMBL3598604	Inhibition of human recombinant TrkA using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	single protein format
CHEMBL3949168	1.0	CC(CO)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cn3)c2)c2cnccc21	CC(CO)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cn3)c2)c2cnccc21	G2 active	External	449.9	2	6	7	4	4	110.0	IC50	'='	nM	62.95	CHEMBL3887111	HTRF Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat#62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors.Assay Details: Invitrogen Amino FAC FAC Assay ReactionTarget Cat# acids enzyme ATP TimeTRKA PV3144 aa 441-4 nM 40 uM 35 min (NTRK1) 796 TRKB PV3616 aa 526-1 nM 1.4 uM 40 min (NTRK2) 838 TRKC PV3617 aa 510- 10 nM 15 uM 30 min (NTRK3) 8250.5 mM stock solutions of test compounds are prepared and serially diluted in 100% DMSO. A standard curve using the compound of Example 135 disclosed in WO2005/116035 of 150 uM is also prepared on each test plate. High percentage effect (HPE) is defined by 150 uM.	single protein format
CHEMBL5078405	1.0	C[C@@H](Nc1ccn2ncc(-c3cnn(C)c3)c2n1)c1cc(F)ccc1OCC(F)F	C[C@@H](Nc1ccn2ncc(-c3cnn(C)c3)c2n1)c1cc(F)ccc1OCC(F)F	G2 active	External	416.41	1	5	7	4	4	69.27	IC50	'='	nM	0.8	CHEMBL5035648	Inhibition of wildtype TRKA (unknown origin) preincubated for 30 mins followed by biotinylated TK-peptide substrate addition and measured after 40 mins by FRET-based Z-lyte kinase assay	single protein format
CHEMBL94678	1.0	COC(=O)[C@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	COC(=O)[C@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	G2 active	External	467.48	2	5	1	8	5	94.72	IC50	'='	nM	1.2	CHEMBL832085	Inhibition of baculovirus expressed human trkA	single protein format
CHEMBL3298451	0.0	O=C(O)c1cc2cnccc2n1CCOc1ccc(OC(F)(F)F)cc1	O=C(O)c1cc2cnccc2n1CCOc1ccc(OC(F)(F)F)cc1	G2 inactive	External	366.29	1	5	6	3	3	73.58	IC50	'='	nM	12300.0	CHEMBL3299478	Inhibition of phsophorylated TrkA (unknown origin) assessed as inhibition of fluorescently-labelled substrate phosphorylation by CALIPER enzymatic assay	single protein format
CHEMBL1397270	0.0	Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C)c2cc1C=O	Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C)c2cc1C=O	G2 inactive	External	270.25	1	5	1	3	3	97.71	IC50	'='	nM	33000.0	CHEMBL3861735	Inhibition of mouse NGF binding to TrkA (unknown origin) by SPR method	single protein format
CHEMBL3318030	0.0	Cn1cc(-c2cnc3ccc(NC(=O)NCCc4ccccc4)nc3c2)cn1	Cn1cc(-c2cnc3ccc(NC(=O)NCCc4ccccc4)nc3c2)cn1	G2 inactive	External	372.43	2	4	5	4	4	84.73	IC50	'='	nM	12670.0	CHEMBL3367500	Inhibition of TrkA (unknown origin)	single protein format
CHEMBL4745330	0.0	COc1cccc2nc(Nc3cccc(NC(=O)c4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)c3)ccc12	COc1cccc2nc(Nc3cccc(NC(=O)c4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)c3)ccc12	G2 inactive	External	535.57	2	6	6	5	4	69.73	IC50	'='	nM	34000.0	CHEMBL4710997	Inhibition of human TRKA using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]ATP by scintillation counting method	single protein format
CHEMBL3671380	0.0	Cc1ccncc1C(=O)Nc1cncc(C(=O)c2cn(C(C)C)c3ncncc23)c1	Cc1ccncc1C(=O)Nc1cncc(C(=O)c2cn(C(C)C)c3ncncc23)c1	G2 inactive	External	400.44	1	6	5	4	4	102.66	IC50	'='	nM	9800000000.0	CHEMBL3887033	Enzyme Assay: Isolated TRK Enzyme assays use the HTRF KinEASE-TK kit (Cisbio Cat# 62TK0PEJ) with recombinant His-tagged cytoplasmic domains of each TRK receptor sourced from Invitrogen (see table below). This activity-assay measures the phosphorylation of tyrosine residues within a substrate from the HTRF kit which has been validated by Cisbio for a variety of tyrosine kinases including the TRK receptors. Assay details: Target:TRKA; Invitrogen Cat# PV3144; Amino acids:aa 441-796; FAC enzyme:4nM; FAC ATP:40uM; Assay Reaction Time:35min.	single protein format
CHEMBL1929238	0.0	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O	G2 inactive	External	554.54	2	4	6	3	2	84.99	IC50	'='	nM	29000.0	CHEMBL1931566	Inhibition of TRKA	single protein format
CHEMBL137953	0.0	Cn1c2ccc(NC(=O)c3ccccc3)cc2c(=O)n2nc(C(=O)O)cc12	Cn1c2ccc(NC(=O)c3ccccc3)cc2c(=O)n2nc(C(=O)O)cc12	G2 inactive	External	362.35	2	5	3	4	4	105.7	IC50	'='	nM	47000.0	CHEMBL3861735	Inhibition of mouse NGF binding to TrkA (unknown origin) by SPR method	single protein format
CHEMBL4790677	0.0	Nc1nc2[nH]c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c2c(=O)[nH]1	Nc1nc2[nH]c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c2c(=O)[nH]1	G2 inactive	External	636.42	3	7	6	6	4	100.52	IC50	'='	nM	12400.0	CHEMBL4674893	Inhibition of human Trk-A using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method	single protein format
CHEMBL3673445	0.0	COc1ccc(COc2ccc(Cn3cnc4cc(C5CCNCC5)ccc43)cc2OC)cn1	COc1ccc(COc2ccc(Cn3cnc4cc(C5CCNCC5)ccc43)cc2OC)cn1	G2 inactive	External	458.56	1	6	8	5	4	70.43	IC50	'='	nM	11100.0	CHEMBL3887112	Inhibition Assay: Reagents and consumables were purchased from Sigma Aldrich, Carna Biosciences, or Caliper Life Sciences. All assay reaction conditions for IC50 determinations were within the linear range with respect to time and enzyme concentration. In a 384 well polypropylene plate, TrkA (0.4 nM, Carna 08-186) was pre-incubated in a 100 mM Hepes-NaOH pH 7.5 buffer containing 0.01% Triton X-100, 10 mM MgCl2, 0.1% BSA, 1 mM DTT, 10 uM sodium orthovanadate and 10 uM beta-glycerophosphate and compound with a concentration of 2.5% DMSO for 15 minutes at room temperature. The reaction was initiated with an equal volume of peptide substrate (Caliper Life Sciences catalog no. 760430) and ATP in the aforementioned buffer. The final concentrations in the reaction were 200 pM TrkA, 1.5 uM peptide substrate and 55 uM ATP (ATP Km). The reaction was incubated at room temperature for 180 minutes and terminated with a buffer containing excess EDTA (100 mM Hepes-NaOH pH 7.5, 0.02% Brij.	single protein format
CHEMBL3629613	0.0	O=C1c2ccccc2-c2c1n(Cc1ccccc1)c1ccccc1c2=O	O=C1c2ccccc2-c2c1n(Cc1ccccc1)c1ccccc1c2=O	G2 inactive	External	337.38	0	2	2	5	5	39.07	IC50	'='	nM	10300.0	CHEMBL3630034	Inhibition of TrkA (unknown origin) by radiometric analysis in presence of [gamma-33P]-ATP	single protein format
CHEMBL3629013	0.0	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1	G2 inactive	External	392.51	1	6	5	5	2	79.0	IC50	'='	nM	464000.0	CHEMBL3631844	Inhibition of TrkA (unknown origin) by FRET method	single protein format
CHEMBL4440381	0.0	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1	G2 inactive	External	464.5	1	6	5	5	4	98.16	Inhibition	'='	%	9.0	CHEMBL4397155	Inhibition of TRKA (unknown origin) at 100 nM by [gamma-33P]ATP-based radiometric or Alphascreen assay relative to control	single protein format
CHEMBL3596897	0.0	Nc1ccc(-c2cncc(-c3ccsc3)n2)cc1	Nc1ccc(-c2cncc(-c3ccsc3)n2)cc1	G2 inactive	External	253.33	1	3	2	3	3	51.8	Inhibition	'='	%	17.0	CHEMBL3598603	Inhibition of human recombinant TrkA at 20 uM using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	single protein format
CHEMBL4129737	0.0	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12	G2 inactive	External	311.35	3	4	3	4	3	95.69	Inhibition	'='	%	1.3	CHEMBL4120840	Inhibition of TRKA (unknown origin) at 0.164 uM relative to control	single protein format
CHEMBL1916891	0.0	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12	G2 inactive	External	432.5	1	5	6	4	4	65.77	Inhibition	'='	%	8.0	CHEMBL1919454	Inhibition of NTRK1 relative to control	single protein format
CHEMBL501471	0.0	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1	G2 inactive	External	452.56	3	6	8	4	4	82.18	Inhibition	'='	%	7.0	CHEMBL965679	Inhibition of TrkA at 10 uM by HTRF assay relative to control	single protein format
CHEMBL483518	0.0	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1	G2 inactive	External	448.53	4	8	8	4	3	125.63	Inhibition	'='	%	7.0	CHEMBL965679	Inhibition of TrkA at 10 uM by HTRF assay relative to control	single protein format
CHEMBL240158	0.0	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1	G2 inactive	External	490.01	2	7	7	4	3	86.28	Inhibition	'='	%	-0.9	CHEMBL901559	Inhibition of TRKA at 10 nM	single protein format
CHEMBL519146	0.0	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1	G2 inactive	External	374.49	1	3	3	4	3	50.16	Inhibition	'='	%	4.0	CHEMBL965679	Inhibition of TrkA at 10 uM by HTRF assay relative to control	single protein format
CHEMBL519311	0.0	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1	G2 inactive	External	419.57	2	8	7	3	1	99.85	Inhibition	'='	%	7.0	CHEMBL965679	Inhibition of TrkA at 10 uM by HTRF assay relative to control	single protein format
CHEMBL1170139	0.0	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1	G2 inactive	External	545.61	2	4	5	5	4	64.26	Inhibition	'='	%	0.3	CHEMBL1175104	Inhibition of TRKA at 10 uM	single protein format
CHEMBL484713	0.0	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1	G2 inactive	External	396.49	0	6	8	3	2	75.63	Inhibition	'='	%	0.0	CHEMBL965679	Inhibition of TrkA at 10 uM by HTRF assay relative to control	single protein format
CHEMBL4278763	0.0	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1	G2 inactive	External	469.57	2	5	4	6	5	116.37	Inhibition	'='	%	15.0	CHEMBL4263965	Inhibition of TRKA (unknown origin) at 1 uM relative to control	single protein format
CHEMBL1483261	0.0	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1	G2 inactive	External	343.46	0	3	2	5	4	29.02	Inhibition	'='	%	4.18	CHEMBL2403997	Inhibition of TRKA (unknown origin) at 10 uM by Z'-LYTE kinase assay	single protein format
CHEMBL560733	0.0	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1	G2 inactive	External	441.5	3	8	7	4	4	132.77	Inhibition	'='	%	-0.14	CHEMBL1055630	Inhibition of TRKA at 10 uM by HotSpot assay relative to control	single protein format
CHEMBL3596863	0.0	COc1ccc(-c2cncc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4C)c3)n2)cc1	COc1ccc(-c2cncc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C)nn4C)c3)n2)cc1	G2 inactive	External	472.55	2	6	6	4	4	103.19	Inhibition	'='	%	15.5	CHEMBL3598603	Inhibition of human recombinant TrkA at 20 uM using ATP and 5FAM tagged TrkA peptide substrate incubated for 60 mins by microfluidics assay	single protein format
CHEMBL3758602	0.0	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21	G2 inactive	External	381.83	3	6	3	5	4	104.4	Inhibition	'='	%	12.6	CHEMBL3761277	Inhibition of TRKA (unknown origin) at 100 nM	single protein format
CHEMBL2331664	0.0	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1	G2 inactive	External	446.51	1	6	3	5	4	106.14	Inhibition	'='	%	9.25	CHEMBL2345839	Inhibition of NTRK1 (unknown origin) at 1 uM	single protein format
CHEMBL3746293	0.0	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1	G2 inactive	External	529.6	3	6	5	6	5	107.94	Inhibition	'='	%	-8.0	CHEMBL3750454	Inhibition of TrkA (unknown origin) at 1 uM	single protein format
CHEMBL519658	0.0	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1	G2 inactive	External	405.51	1	6	8	4	3	79.18	Inhibition	'='	%	11.0	CHEMBL965679	Inhibition of TrkA at 10 uM by HTRF assay relative to control	single protein format
CHEMBL3735890	0.0	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O	G2 inactive	External	405.46	2	7	4	5	3	92.37	Inhibition	'='	%	10.3	CHEMBL3738546	Inhibition of TRKA (unknown origin) at 200 nM by electrophoretic mobility shift assay	single protein format
CHEMBL519534	0.0	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1	G2 inactive	External	499.64	1	7	7	5	4	77.49	Inhibition	'='	%	8.0	CHEMBL965679	Inhibition of TrkA at 10 uM by HTRF assay relative to control	single protein format
CHEMBL4094080	0.0	N[C@H]1C[C@H](Oc2ccc3ncc(-c4ccc5cnccc5c4)n3n2)C1	N[C@H]1C[C@H](Oc2ccc3ncc(-c4ccc5cnccc5c4)n3n2)C1	G2 inactive	External	331.38	1	5	3	5	4	78.33	Inhibition	'='	%	17.0	CHEMBL4048664	Inhibition of TRKA (unknown origin) at 1 uM relative to control	single protein format
CHEMBL3264107	0.0	CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1	CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1	G2 inactive	External	411.44	1	6	9	3	3	73.34	Inhibition	'='	%	8.0	CHEMBL3267961	Inhibition of TrkA (unknown origin) at 1 uM	single protein format
CHEMBL521145	0.0	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1	G2 inactive	External	384.49	0	6	5	4	3	68.94	Inhibition	'='	%	5.0	CHEMBL965679	Inhibition of TrkA at 10 uM by HTRF assay relative to control	single protein format
CHEMBL446637	0.0	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1	G2 inactive	External	610.19	0	7	7	7	5	69.87	Inhibition	'='	%	5.0	CHEMBL965679	Inhibition of TrkA at 10 uM by HTRF assay relative to control	single protein format
CHEMBL2402081	0.0	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1	G2 inactive	External	432.46	0	6	4	5	4	84.97	Inhibition	'='	%	20.0	CHEMBL2406550	Inhibition of NTRK1 (unknown origin) at 10 uM relative to control	single protein format
CHEMBL607535	0.0	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21	G2 inactive	External	276.3	1	2	0	4	2	49.41	Inhibition	'='	%	20.0	CHEMBL1066106	Inhibition of TRKA at 10 uM	single protein format
CHEMBL2216825	0.0	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O	G2 inactive	External	457.48	2	9	2	5	1	122.6	Inhibition	'='	%	14.0	CHEMBL1019629	Inhibition of NTRK1 at 1 uM	single protein format
CHEMBL4207014	0.0	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1	G2 inactive	External	405.44	2	7	3	5	5	132.44	Inhibition	'='	%	2.0	CHEMBL4191216	Inhibition of recombinant human TrkA (440 to end residues) at 1 uM using KKKSPGEYVNIEFG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	single protein format
CHEMBL518248	0.0	COCCCNC(=O)N/N=C/c1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F	COCCCNC(=O)N/N=C/c1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F	G2 inactive	External	609.34	5	6	12	2	2	133.31	Inhibition	'='	%	0.0	CHEMBL1011755	Binding affinity to TrkA at 10 uM	single protein format
CHEMBL3601472	0.0	CS(=O)(=O)NCc1ccc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nn12	CS(=O)(=O)NCc1ccc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nn12	G2 inactive	External	404.46	2	9	5	4	3	140.63	Inhibition	'='	%	-2.0	CHEMBL3603012	Inhibition of recombinant TRKA (unknown origin) at 1 uM after 3 hrs	single protein format
CHEMBL2012574	0.0	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1	G2 inactive	External	337.35	1	3	5	3	3	53.07	Inhibition	'='	%	8.0	CHEMBL2014513	Inhibition of TRKA at 10 uM	single protein format
CHEMBL3319470	0.0	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N	G2 inactive	External	375.43	2	5	5	4	4	82.39	Inhibition	'='	%	11.0	CHEMBL3368579	Inhibition of TRKA (unknown origin) at 1 uM by KINOMEscanning assay relative to control	single protein format
CHEMBL4247506	0.0	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21	G2 inactive	External	472.47	1	5	2	5	5	82.51	Inhibition	'='	%	2.0	CHEMBL4230244	Inhibition of TRKA (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	single protein format
CHEMBL3628628	0.0	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	G2 inactive	External	453.93	2	5	9	4	4	94.06	Inhibition	'='	%	5.11	CHEMBL3631502	Inhibition of TRKA (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	single protein format
CHEMBL3815093	0.0	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	G2 inactive	External	417.49	2	8	7	3	3	105.68	Inhibition	'='	%	-2.0	CHEMBL3816865	Inhibition of human TRKA at 1 uM using poly[Glu:Tyr] (4:1) as substrate	single protein format
CHEMBL3113284	0.0	COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC	COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC	G2 inactive	External	509.57	3	9	7	5	5	139.32	Inhibition	'='	%	9.0	CHEMBL3117481	Inhibition of TRKA (unknown origin) at 10 uM after 30 mins relative to control	single protein format
CHEMBL5081774	0.0	[2H]C([2H])([2H])C1(C([2H])([2H])[2H])Cn2nc(-c3ccc(F)cn3)c(-c3ccnc4[nH]ncc34)c2CO1	[2H]C([2H])([2H])C1(C([2H])([2H])[2H])Cn2nc(-c3ccc(F)cn3)c(-c3ccnc4[nH]ncc34)c2CO1	G2 inactive	External	370.42	1	5	4	5	4	81.51	Inhibition	'='	%	-12.0	CHEMBL5059346	TrkA(h) Kinase panel	single protein format
CHEMBL4528675	0.0	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	G2 inactive	External	535.55	1	7	7	5	4	107.06	Inhibition	'='	%	5.12	CHEMBL4366623	Inhibition of human TRKA at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	single protein format
CHEMBL4249147	0.0	COc1ccc2c(OCc3nnc4sc(-c5cnn(C)c5)nn34)ccnc2c1	COc1ccc2c(OCc3nnc4sc(-c5cnn(C)c5)nn34)ccnc2c1	G2 inactive	External	393.43	0	7	5	5	5	92.25	Inhibition	'='	%	-11.8	CHEMBL4231731	Inhibition of GST-tagged human TRKA at 5 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-Spot kinase assay	single protein format
CHEMBL1684662	0.0	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1	G2 inactive	External	352.4	2	3	4	5	5	74.43	Inhibition	'='	%	2.0	CHEMBL1685880	Inhibition of TrkA at 0.1 uM	single protein format
CHEMBL185238	0.0	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1	G2 inactive	External	287.33	1	4	2	4	4	67.35	Inhibition	'='	%	-0.6	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL1880739	0.0	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1	G2 inactive	External	520.95	2	2	1	3	2	49.33	Inhibition	'='	%	5.43	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL1909347	0.0	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1	G2 inactive	External	430.31	3	5	3	4	3	94.14	Inhibition	'='	%	2.36	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL1909358	0.0	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1	G2 inactive	External	452.54	2	8	7	4	4	113.1	Inhibition	'='	%	7.28	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1909367	0.0	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1	G2 inactive	External	551.48	4	6	5	4	4	142.28	Inhibition	'='	%	2.0	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1909377	0.0	c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1	c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1	G2 inactive	External	305.34	0	4	2	5	3	49.17	Inhibition	'='	%	2.3	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1909402	0.0	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1	G2 inactive	External	373.31	1	4	2	4	4	69.1	Inhibition	'='	%	-3.76	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1909408	0.0	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1	G2 inactive	External	579.69	2	8	5	7	5	106.43	Inhibition	'='	%	0.63	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL1909414	0.0	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1	G2 inactive	External	453.55	2	5	7	5	4	86.63	Inhibition	'='	%	1.3	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL194062	0.0	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1	G2 inactive	External	315.35	2	5	4	3	3	98.22	Inhibition	'='	%	6.9	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL205158	0.0	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1	G2 inactive	External	427.51	1	6	7	5	4	76.16	Inhibition	'='	%	-2.28	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL2062289	0.0	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1	G2 inactive	External	400.43	2	5	5	4	3	86.8	Inhibition	'='	%	-1.94	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL231623	0.0	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N	G2 inactive	External	307.33	2	3	3	3	3	82.0	Inhibition	'='	%	0.97	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL272026	0.0	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1	G2 inactive	External	467.51	4	6	8	4	3	160.57	Inhibition	'='	%	7.16	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL318892	0.0	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1	G2 inactive	External	428.52	1	5	5	5	4	58.87	Inhibition	'='	%	0.86	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL346551	0.0	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1	G2 inactive	External	264.28	2	3	3	3	2	58.2	Inhibition	'='	%	2.8	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL347580	0.0	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1	G2 inactive	External	320.35	1	4	3	4	2	58.64	Inhibition	'='	%	4.34	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL362155	0.0	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1	G2 inactive	External	490.45	1	7	4	6	5	86.46	Inhibition	'='	%	2.6	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL373073	0.0	COc1ccc(-c2cc3c(N)ncnc3o2)cc1	COc1ccc(-c2cc3c(N)ncnc3o2)cc1	G2 inactive	External	241.25	1	5	2	3	3	74.17	Inhibition	'='	%	1.06	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL374060	0.0	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1	G2 inactive	External	325.41	1	4	3	2	2	59.42	Inhibition	'='	%	3.16	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL397570	0.0	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2	G2 inactive	External	300.36	1	2	2	3	2	52.89	Inhibition	'='	%	-0.1	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL399410	0.0	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1	G2 inactive	External	453.57	0	4	5	5	5	63.0	Inhibition	'='	%	2.26	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL476351	0.0	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1	G2 inactive	External	470.57	2	5	7	5	3	83.56	Inhibition	'='	%	0.24	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL483747	0.0	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1	G2 inactive	External	390.46	1	4	5	4	4	82.28	Inhibition	'='	%	3.48	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL485598	0.0	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1	G2 inactive	External	494.45	3	4	4	5	4	95.06	Inhibition	'='	%	4.04	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL486124	0.0	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12	G2 inactive	External	352.44	1	6	6	4	3	67.58	Inhibition	'='	%	2.68	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL505187	0.0	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1	G2 inactive	External	528.62	3	4	8	6	6	96.86	Inhibition	'='	%	-2.04	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL506153	0.0	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21	G2 inactive	External	330.35	3	8	6	3	3	136.78	Inhibition	'='	%	2.52	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL513330	0.0	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1	G2 inactive	External	336.79	1	5	4	4	4	68.0	Inhibition	'='	%	1.23	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL517171	0.0	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1	G2 inactive	External	568.05	4	8	10	5	4	130.42	Inhibition	'='	%	3.68	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL522709	0.0	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1	G2 inactive	External	461.47	1	4	6	4	4	79.37	Inhibition	'='	%	1.11	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL529066	0.0	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1	G2 inactive	External	563.08	2	8	11	5	5	106.35	Inhibition	'='	%	3.58	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL581096	0.0	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12	G2 inactive	External	327.39	2	4	3	4	4	58.04	Inhibition	'='	%	4.17	CHEMBL1962184	GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL69757	0.0	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1	G2 inactive	External	362.37	1	5	5	4	4	77.22	Inhibition	'='	%	3.42	CHEMBL1962185	GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn]	single protein format
